The white blood cell adhesion molecule E-selectin predicts restenosis in patients with intermittent claudication undergoing percutaneous transluminal angioplasty

Circulation

Volumn 95, Issue 8, 1997, Pages 2027-2031

  Belch, J J F ^a   Shaw, J W ^a   Kirk, G ^a   McLaren, M ^a   Robb, R ^a   Maple, C ^a   Morse, P ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b Scotia Pharmaceuticals Ltd   (United Kingdom)

Author keywords

angioplasty; blood cells; endothelium; peripheral vascular disease; restenosis

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECURRENCE RISK; RESTENOSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0030891511     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.8.2027     Document Type: Article

References (36)

1. Dormandy J, Mahir M, Ascady G, Balsano S, De Leeuw P, Blombery P. Fate of a patient with chronic leg ischaemia. J Cardiovasc Surg. 1989;30:50-57.
2. Dormandy JA. Natural history of intermittent claudication. Hosp Update. 1991;17:314-320.
3. Cronenwett JL, Warner KG, Zelenock JB, Whitehouse WM, Graham LM, Lindenauer SM. Intermittent claudication: current results of non-operative management. Arch Surg. 1984;119:430-436.
4. Jorgensen B. Percutaneous transluminal angioplasty for distal iliac artery stenosis. Crit Ischaem. 1995;5:28-32.
5. Morin JF, Johnston WK, Wasserman L. Factors that determine the long term results of percutaneous transluminal dilatation for peripheral arterial occlusive disease. J Vasc Surg. 1986;4:68-72.
6. El-Bayar H, Roberts A, Hye R, Davis G, Freischlag J. Determinants of failure in superficial femoral artery angioplasty. J Vasc Surg. 1994;28:539-547.
7. Wilson SE, Wolf GL, Cross AP. Percutaneous transluminal angioplasty versus operation for peripheral arterial sclerosis: report of a randomised trial in a selected group of patients. J Vasc Surg. 1989; 9:1-9.
8. Rooke TW, Stanson AW, Johnson CM. Percutaneous transluminal angioplasty in the lower extremities: a 5 year experience. Mayo Clin Proc. 1987;62:85-91.
9. Mattson E, Jansen I, Edvinsson L, Bergqvist D. Endothelial influence on vessel wall induced vasospasm after balloon angioplasty. Acta Radiol. 1993;34:156-161.
10. Minar E, Ehringer H, Ahmadi R, Dudczak R. Platelet deposition at angioplasty sites and its relation to restenosis in human iliac and femoropopliteal arteries. Radiology. 1989;170:767-772.
11. Spence RK, Freiman DB, Gatenby R, Hobbs CL, Barker CF, Berkowitz HD, Roberts B, MacLean G, Oleaga J, Ring EJ. Long term results of transluminal angioplasty of the iliac and femoral arteries. Arch Surg. 1981;116:1377-1386.
12. Gardener GA, Meyerobitz MF, Stokes KR, Clouse ME, Harrington DP, Bettmann MA. Complications of transluminal angioplasty. Radiology. 1986;159:201-208.
13. Waller BF, Pingkerton CA, Orr CM, Slack JD, VanTassel JW, Peters T. Morphological observations late (>30°) after clinically successful coronary balloon angioplasty. Circulation. 1991;83:28-41.
14. Liu MW, Roubin GS, Robinson KA, Black AJ, Hearn JA, Siegal RJ, King SB. Trapidil in preventing restenosis after balloon angioplasty in the atherosclerotic rabbit. Circulation. 1990;81:1089-1093.
15. Casscells W, Lappi DA, Olwin BB, Yai C, Siegman M, Speir EH, Sasse J, Baird A. Elimination of smooth muscle cells in experimental restenosis targeting of fibroblast growth factor receptors. Proc Natl Acad Sci U S A. 1992;89:7159-7163.
16. Dzau VJ, Gibbons GH, Cooke JP, Omoigui N. Vascular biology and medicine in the 1990s: scope, concepts, potentials, and perspectives. Circulation. 1993;87:705-719.
17. Springer TA. Adhesion receptors of the immune system. Nature. 1990;346:425-434.
18. Newman W, Beall LD, Carson CW, Hunder GG, Graben N, Randhawa ZI, Gopal TV, Wiener-Kronish J, Matthay MA. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol. 1993;150:644-654.
19. Gimbrone MA, Devilacqua MP, Cybulsky MI. Endothelial dependent mechanisms of leukocyte adhesion in inflammation and atherosclerosis. Ann N Y Acad Sci. 1990;598:77-85.
20. Belch JJF, Zoma A, Richards I, Forbes CD, Sturrock RD. Vascular damage and factor VIII related antigen in the rheumatic disease. Rheumatol Int. 1987;7:107-111.
21. 2) on human neutrophils. J Exp Med. 1991;173:1493-1500.
22. Kirk G, Hickman P, McLaren M, Burslem F, McCollum PT, Belch JJF. Does interleukin 8 contribute to the activation of neutrophils in peripheral arterial disease? Br J Haematol. 1994;86:16. Abstract.
23. Maple C, Kirk G, McLaren M, Belch JJF. Circadian variation exists for soluble ICAM-1 and soluble E-selectin in healthy volunteers. Br J Rheumatol. 1995;34(suppl 1):188. Abstract.
24. Belch JJF, Chopra M, Hutchison S, Lorimer R, Sturrock RD, Forbes CD, Smith E. Free radical pathology in chronic arterial disease. Free Radic Biol Med. 1989;6:375-378.
25. Breslow NE, Day NE. Statistical Methods in Cancer Research Vol. 2. The Design and Analysis of Cohort Studies. Lyon, France: IARC Scientific Publications; 1987:82.
26. Altman D. Practical Statistics for Medical Research. London UK: Chapman and Hall; 1991.
27. Smith CW, Kishimoto TK, Abbass O, Hughes B, Rothlein R, McIntire LV, Butcher E, Anderson DC. Chemotactic factors regulate lectin adhesion molecule 1 (LECAM-1)-dependent neutrophil adhesion to cytokine-stimulated endothelial cells in vitro. J Clin Invest. 1991;87:609-618.
28. Ley K, Gaehtgens P, Fennie C, Singer MS, Lasky LA, Rosen SD. Lectin-like cell adhesion molecule-1 mediates leukocyte rolling in mesenteric venules in vivo. Blood. 1991;77:2553-2555.
29. Geng JG, Bevilacqua MP, Moore KL, McIntyre TM, Prescott SM, Kim JM, Bliss GA, Zimmermann GA, McEver RP. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature. 1990;343:757-760.
30. Luscinskas FW, Cybulsky MI, Kiely JM, Peckins CS, Davis VM, Gimbrone MA. Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intracellular adhesion molecule-1. J Immunol. 1991;146:1617-1625.
31. Belch JJF. The white blood cell as a risk factor for thrombotic vascular disease. Vasc Med Rev. 1990;1:203-213.
32. Lau CS, Scott N, Brown JE, Shaw W, Belch JJF. Increased activity of oxygen free radicals during reperfusion in patients undergoing percutaneous peripheral artery balloon angioplasty. Int Angiol. 1991;10:244-246.
33. Ferns JA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross K. Inhibition of neo-intimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 1991;253:1129-1132.
34. Austin GE, Lynn M, Hollman J. Laboratory test results as predictors of recurrent coronary artery stenosis following angioplasty. Arch Pathol Lab Med. 1987;111:1158-1162.
35. Romo IA, Miquel MC, Antolin HR, Larre CJ, Manterola AF, Ruigmez GJ, Gutierrez ZP. The effects of ticlopidine administration at low doses on the instance of restenosis following percutaneous transluminal coronary angioplasty. Res Exp Cardiol 1991; 44:366-374.
36. Hunink MGM, Cullen KA, Donaldson MC. Hospital costs of revascularization procedures for femoropopliteal arterial disease. J Vasc Surg. 1994;19:633-641.